Novel biomaterials to prevent dental peri-implant infections

NOMAD is a EU-funded research and innovation collaborative project aimed at developing the next generation of dental implants that can prevent peri-implant diseases. Scientists and dental specialists from 10 organizations in 7 European countries have joined forces to tackle the increasing socio-economic burden associated with these diseases.

43%

of dental implant patients develop peri-implant mucositis

22%

of dental implant patients develop peri-implantitis

Peri-implant infections, a devastating complication of dental implants

Despite the high success rate for dental implant procedures, a high number of patients develop peri-implant infections, which can ultimately lead to implant instability and bone loss. Microorganisms sticking to implant surface and forming recalcitrant biofilms are a particular point of concern.

To address these unmet clinical needs and contribute to overall patient wellbeing, NOMAD will apply multiple biomaterial innovations that promote tissue integration and prevent or control biofilm formation to various implant components, thereby avoiding peri-implant diseases and increasing implant longevity.

NOMAD - dental implants

Meet the team

NOMAD brings together 10 partner organizations from 7 European countries, gathering academic, clinical, SME and industry experts in:

NOMAD in numbers

The NOMAD project has received funding from the European Union’s Horizon Europe programme under grant agreement no. 101091669.

NOMAD - dental implants
50% women

as team leaders

NOMAD - dental implants
7

EU countries

NOMAD - dental implants
50%

academics

NOMAD - dental implants
10

partners

NOMAD - dental implants
54 months

duration

NOMAD - dental implants
€ 4.708.219

EU contribution

Flag of Europe

Funded by the European Union

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.